243 related articles for article (PubMed ID: 18948500)
1. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats.
Trezza V; Vanderschuren LJ
J Pharmacol Exp Ther; 2009 Jan; 328(1):343-50. PubMed ID: 18948500
[TBL] [Abstract][Full Text] [Related]
2. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
3. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Rockwell CE; Kaminski NE
J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
[TBL] [Abstract][Full Text] [Related]
4. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
[TBL] [Abstract][Full Text] [Related]
5. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
Kelley BG; Thayer SA
Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
[TBL] [Abstract][Full Text] [Related]
6. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
Borsani E; Labanca M; Bianchi R; Rodella LF
Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
[TBL] [Abstract][Full Text] [Related]
7. Anandamide transporter-mediated regulation of the micturition reflex in urethane-anesthetized rats.
Honda M; Yoshimura N; Kawamoto B; Hikita K; Muraoka K; Shimizu S; Saito M; Chancellor MB; Takenaka A
Int Urol Nephrol; 2016 Sep; 48(9):1407-12. PubMed ID: 27256398
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1).
McVey DC; Schmid PC; Schmid HH; Vigna SR
J Pharmacol Exp Ther; 2003 Feb; 304(2):713-22. PubMed ID: 12538826
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
11. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
[TBL] [Abstract][Full Text] [Related]
12. The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes.
Oz M; Ravindran A; Diaz-Ruiz O; Zhang L; Morales M
J Pharmacol Exp Ther; 2003 Sep; 306(3):1003-10. PubMed ID: 12766252
[TBL] [Abstract][Full Text] [Related]
13. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
[TBL] [Abstract][Full Text] [Related]
14. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
de Lago E; de Miguel R; Lastres-Becker I; Ramos JA; Fernández-Ruiz J
Brain Res; 2004 May; 1007(1-2):152-9. PubMed ID: 15064146
[TBL] [Abstract][Full Text] [Related]
15. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
Giuffrida A; Rodriguez de Fonseca F; Nava F; Loubet-Lescoulié P; Piomelli D
Eur J Pharmacol; 2000 Nov; 408(2):161-8. PubMed ID: 11080522
[TBL] [Abstract][Full Text] [Related]
16. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
17. Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration.
Reyes-Cabello C; Alen F; Gómez R; Serrano A; Rivera P; Orio L; Rodríguez de Fonseca F; Pavón FJ
Pharmacol Biochem Behav; 2012 Mar; 101(1):1-7. PubMed ID: 22133635
[TBL] [Abstract][Full Text] [Related]
18. The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.
Oz M; Yang KH; Dinc M; Shippenberg TS
J Pharmacol Exp Ther; 2007 Nov; 323(2):547-54. PubMed ID: 17682128
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
[TBL] [Abstract][Full Text] [Related]
20. Bidirectional cannabinoid modulation of social behavior in adolescent rats.
Trezza V; Vanderschuren LJ
Psychopharmacology (Berl); 2008 Apr; 197(2):217-27. PubMed ID: 18058088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]